⚠️ RESEARCH USE ONLY - NOT FOR HUMAN CONSUMPTION - NOT APPROVED BY MHRA - 18+ ONLY

Verified Peptides

Cagrilintide Research & Scientific Studies

Explore the latest peer-reviewed research and scientific studies

About Cagrilintide

Cagrilintide is studied as a long-acting amylin analogue in metabolic research. Supplied as a lyophilized powder for laboratory investigations of amylin receptor pharmacology, satiety-associated signaling markers, and glucose-regulatory mechanisms in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.

Purity99
Categorypeptide

Latest Research

Featured Study

Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study.

Aroda VR et al.Lancet Diabetes Endocrinol2026

Recent research on Cagrilintide: Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-c

Read Full Study on PubMed
Featured Study

Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial.

Loomba R et al.Lancet Gastroenterol Hepatol2026

Recent research on Cagrilintide: Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-b

Read Full Study on PubMed

Additional Studies

Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials.

Alhazmi A et al.Diabetes Obes Metab2026

Recent research on Cagrilintide: Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials.

Read on PubMed

Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.

Rosenstock J et al.Lancet2026

Recent research on Cagrilintide: Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.

Read on PubMed

Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta-Analysis of Randomized Clinical Trials.

Hamarsheh S et al.Endocrinol Diabetes Metab2026

Recent research on Cagrilintide: Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta-Analysis of Randomized Clinical Trials.

Read on PubMed

Ease of Use, Ease of Learning, and Convenience of the CagriSema Dual-Chamber Pen: Results From a Usability Study in Adults With Overweight, Obesity, or Type 2 Diabetes.

Gulisano W et al.J Diabetes Sci Technol2026

Recent research on Cagrilintide: Ease of Use, Ease of Learning, and Convenience of the CagriSema Dual-Chamber Pen: Results From a Usability Study in Adults With Overweight, Obesity, or Type 2 Diabetes.

Read on PubMed

Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.

Damen JAA et al.Ann Intern Med2026

Recent research on Cagrilintide: Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.

Read on PubMed

In vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive doping research.

Alhalabi H et al.J Pharm Biomed Anal2026

Recent research on Cagrilintide: In vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive doping research.

Read on PubMed

Related Research

Purchase Cagrilintide from Verified Peptides

High-purity research peptides with full analytical verification

  • 99% Purity (HPLC Verified)
  • Full Certificate of Analysis
  • Same Day Dispatch
  • Free UK Shipping Over £75
Buy Cagrilintide - 99% Purity, Same Day Dispatch

Research Disclaimer

The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.